Zevra Therapeutics (ZVRA) Goodwill (2023 - 2026)

Zevra Therapeutics has reported Goodwill for 4 years, with the latest figure at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill changed 0.02% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (changed 0.02% YoY), and the FY2025 full-year result was $4.7 million, changed 0.02% from the prior year.
• Goodwill for Q1 2026 stood at $4.7 million, roughly flat from $4.7 million in the prior quarter.
• The five-year high for Goodwill was $4.7 million in Q4 2023, with the low at $4.7 million in Q1 2024.
• Historically, Goodwill has averaged $4.7 million across 4 years, with a median of $4.7 million in 2024.
• The largest YoY upside for Goodwill was 0.02% in 2025 against a maximum downside of 0.02% in 2025.
• Zevra Therapeutics' Goodwill stood at $4.7 million in 2023, then changed by 0.0% to $4.7 million in 2024, then retreated by 0.02% to $4.7 million in 2025, then changed by 0.0% to $4.7 million in 2026.
• The last three Goodwill figures came in at $4.7 million (Q1 2026), $4.7 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.